Dr. Kaplan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12208 W 87th Street Pkwy
Ste 180
Lenexa, KS 66215Phone+1 913-438-0868Fax+1 913-338-1311
Education & Training
University of Iowa Hospitals and ClinicsResidency, Neurology, 1988 - 1991- University of Iowa Hospitals and ClinicsInternship, Internal Medicine, 1987 - 1988
University of Kansas School of MedicineClass of 1987
Certifications & Licensure
KS State Medical License 2003 - 2025- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Publications & Presentations
PubMed
- 37 citationsIntracerebral haemorrhage during alemtuzumab administration.Christina J. Azevedo, Christen Kutz, Amy Dix, Aaron Boster, Nerses Sanossian
The Lancet. Neurology. 2019-02-15 - 7 citationsA Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse.Jeffrey Kaplan, Tamara Miller, Matthew Baker, Bryan Due, Enxu Zhao
Frontiers in Neurology. 2020-12-22 - 2 citationsRepository corticotropin injection improves quality metrics in an observational study of multiple sclerosis relapse.Jeffrey Kaplan, Tamara Miller, Matthew L. Baker, Bryan Due, Enxu Zhao
Neurodegenerative Disease Management. 2021-12-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
